Searched for
DASATINIB
Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...06 Mar, 2025, 10.03 AM IST- Lupin gets USFDA nod for generic cancer treatment drugLupin in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in ...29 Aug, 2022, 05.09 PM IST
- Alembic gets USFDA nod for cancer treatment drugDasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) i...10 Jun, 2022, 12.19 PM IST
- Shilpa Medicare launches cancer drug at monthly therapy cost of Rs 6,440The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on 12 April 12, 2020. The current monthly therapy ...24 Apr, 2020, 10.56 AM IST
- Delhi HC Upholds BMS' Patent for Cancer Drug DasatinibThe Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of...07 Jul, 2015, 10.50 AM IST
- Delhi High Court upholds BMS’ patent for cancer drug DasatinibThe Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaini...06 Jul, 2015, 05.37 AM IST
- US asked not to pressurise India to reject drug licenseUACT is an international network of people affected by cancer who share the conviction that cancer treatment and care should be available e...31 Oct, 2014, 10.08 AM IST
- DIPP seeks details on blood cancer drug Dasatinib for issuance of compulsory licencesThe ministry has sought details from the Health Ministry, which had approached the DIPP for issuance of compulsory licences.19 Oct, 2014, 11.59 AM IST
- DIPP defers decision on issuance of compulsory licence for cancer drug Dasatinib“DIPP has sought further information to justify the issuance of a CL under Section 92 of Indian Patents Act,” said an official privy to the...16 Oct, 2014, 04.00 AM IST
- Government mulls cancer drug patent waiver for DasatinibHealth ministry reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a cancer drug, arguing the move is needed ...05 May, 2014, 08.54 AM IST
- Cheaper version of cancer drug Dasatinib will have to waitDIPP has shot down a health ministry proposal to consider a government-initiated compulsory licence for cancer drug Dasatinib.27 Mar, 2014, 01.17 PM IST
- Cancer drug may lose patent shieldA compulsory licence (CL) will allow the government to source generic versions of the patented drug and sell them at a fraction of the cost.07 Feb, 2014, 11.31 AM IST
- BDR Pharmaceutical's plea for compulsory licence on cancer drug rejectedThe Indian Patent Office has rejected Mumbai-based BDR Pharmaceutical’s application for compulsory licence on cancer drug Dasatinib.12 Sep, 2013, 04.55 AM IST
- BDR Pharma seeks cancer drug licenceBDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib19 Mar, 2013, 10.52 AM IST
- Delhi High Court gives Natco Pharma a week to respond to Bristol-Myers Squibb contempt chargesDelhi HC has given Natco Pharma a week's time to respond to the contempt charges slapped by American firm Bristol-Myers Squibb (BMS).04 Aug, 2012, 04.52 PM IST
- Natco Pharma, Bristol-Myers Squibb face off in Court over sale of dasatinib cloneHyderabad-based Natco says it has not reneged on its undertaking as its version of the drug is different and does not infringe upon the pat...01 Aug, 2012, 05.22 AM IST
- Natco Pharma begins sales of Bristol Myers' cancer drug DasatinibHyderabad-based generic drugmaker Natco Pharma has started selling copies of global pharma major Bristol Myers Squibb's cancer drug Dasatin...13 Jul, 2012, 02.35 AM IST
Load More
